Synthetic process method for novel antineoplastic molecular targeted drug of crizotinib

An anti-tumor molecule, crizotinib technology, applied in organic chemistry methods, chemical instruments and methods, preparation of hydroxyl compounds, etc., can solve problems such as unsatisfactory yield and waste

Active Publication Date: 2014-03-26
济南良福精合医药科技有限公司
View PDF3 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the original process, when resolving 1-(2,6-dichloro-3-fluorophenyl)ethanol, due to the R and S configurations each accounting for 50%, (R)-1-(2, 6-dichloro-3-fluorophenyl)ethanol (BP2) was discarded after resolution, while (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol (TM2) was only 60% of which can be

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic process method for novel antineoplastic molecular targeted drug of crizotinib
  • Synthetic process method for novel antineoplastic molecular targeted drug of crizotinib
  • Synthetic process method for novel antineoplastic molecular targeted drug of crizotinib

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0095] Example 1: Synthesis of racemic 1-(2,6-dichloro-3-fluorophenyl)ethanol (TM1)

[0096] In a 5L three-neck flask, add 832 grams of SM1 to a mixed solvent of 1.5L ethanol and 1.5L THF, heat the solution to 35°C, add 182 grams of sodium borohydride, the reaction is exothermic, and bubbles are generated, and the reaction is completed after 2 hours. Add 50 g of sodium borohydride, and TLC detects that the reaction is complete in 2 hours (PE / EA=10:1). Add 200 g of water to the system, stir for half an hour, a large amount of solids appear, remove the solvent under reduced pressure, add water and ethyl acetate for extraction, wash the ethyl acetate layer with salt, dry and spin dry to obtain 800 g of product TM1, the yield is 97%. 1 H NMR (400MHz, DMSO-d 6 )δppm7.42(m,1H),7.32(m,1H),5.42(m,2H),1.45(d,J=6.4Hz,3H).

example 2

[0097] Example 2: Preparation of (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol (TM2)

[0098] 500 grams of TM1, 322 grams of Boc-L-proline were dissolved in 1.5L of anhydrous dichloromethane, and 2.5L of dichloromethane solution of 375 grams of EDCI and 118 grams of p-toluenesulfonic acid was added dropwise at 0°C, and the addition was completed Afterwards, the reaction was carried out at room temperature for 2 hours, and the reaction was monitored by TLC (PE / EA=5:1). The reaction solution was washed with water, dried, and evaporated to dryness. The fraction at 100-110°C was collected under reduced pressure with an oil pump at a vacuum of 10 mm Hg to obtain an oily crude product. The crude product was dissolved in 250 mL of n-hexane at room temperature, and the product precipitated when the temperature dropped to -20°C. Filtration at low temperature yielded 150 g of a white solid, with a yield of 60% based on the single configuration and 30% based on the total amount (ee%>98%). ...

example 3

[0108] Example 3: Synthesis of (R)-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-2-nitropyridine (TM3)

[0109] 300 grams of TM2, 205 grams of SM2 and 540 grams of triphenylphosphine were dissolved in 2L THF, and 361 grams of DEAD was added dropwise at 0°C. After the addition was completed, it was stirred at room temperature for two hours, and the reaction was detected by TLC. (PE / EA =3:1). Remove THF by rotary evaporation, add water, extract with ethyl acetate 1Lx3, wash the ethyl acetate layer with saturated aqueous sodium bicarbonate solution, dry the ethyl acetate layer and concentrate to 2L, cool down to 0°C to precipitate a large amount of solids, remove by filtration, and concentrate the filtrate to 1L, solid precipitated after cooling down, filtered, combined the solids obtained by the two filtrations, washed with PE / EA=5:1 solution, filtered, removed the solid (about 500g), combined the filtrates and removed the solvent under reduced pressure to obtain a crude product. 4...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a synthetic process method for a novel antineoplastic molecular targeted drug of crizotinib, and relates to the resolution process optimization of chiral isomers of a crizotinib precursor and the recycling of by-products. The method adopts a catalyzing resolution method that Boc-L-proline, namely, N-(tert-butoxycarbonyl)-L-proline) is combined with a catalyst of p-toluenesulfonic acid and a condensating agent of 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride to split 1-(2,6-dichloro-3-fluorophenyl)ethanol racemate into S-type alcohol and R-type alcohol, and a resolution by-product mixture is subjected to hydrolysis and configuration transition to obtain the (S)-1-(2,6-dichloro-3-fluorophenyl)ethanol; the total yield is improved to 76% from 30%, the time is shortened, pollution is reduced, and application to industrialized production is easy.

Description

Technical field: [0001] The invention belongs to the field of pharmacy, and specifically relates to a new synthesis method of anti-tumor molecular targeting drug crizotinib, which involves the optimization of the resolution process of chiral isomers of the precursor of crizotinib. Product recovery and utilization, and synthesis methods of intermediates. Background technique: [0002] The anti-tumor molecular targeted drug crizotinib, also known as crizotinib, has a chemical name of: [0003] 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidine)-1H-pyrazol-4-yl]- 2-Pyridinamine, the molecular formula is: [0004] [0005] Crizotinib was approved by the US Food and Drug Administration (FDA) for the treatment of advanced non-small cell lung cancer (NSCLC) on August 26, 2011. [0006] The synthetic route of existing reported crizotinib is: [0007] With 2,6-dichloro-3-fluoroacetophenone (SM1) as the starting material, racemized 1-(2,6-dichloro-3-fluorophenyl)...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D401/14C07D207/16
CPCC07B2200/07C07C29/095C07C29/56C07C29/88C07D401/14C07C33/46
Inventor 孙学英李杰李万湖高砚芳张坤
Owner 济南良福精合医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap